This article describes the contribution that Israel’s Teva makes to GDP and employment in 19 of the 60 countries that it operates in. It is in addition to the medical benefits and the world’s largest generic medicine manufacturer’s role in keeping personal and national treatment costs down. It saved the US Healthcare system $41 billion in 2018 and contributed some $15 billion to US GDP.

https://www.calcalistech.com/ctech/articles/0,7340,L-3780771,00.html

https://www.tevapharm.com/our-impact/economic-impact-report/